Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Key Financial Highlights for Q1 2022
Revenue increased 606% to $1.9 million
Gross profit increased 291% to $0.7 million
Adjusted EBITDA loss decreased 30% to $0.9 million
Total assets increased to $17.0 million
Total stockholders’ equity increased to $6.2 million
Key Business Highlights for Q1 2022
https://www.otcmarkets.com/stock/CANB/news/Can-B-Corp-Reports-First-Quarter-Revenue-Growth-of-606-to-19-Million-the-Highest-Quarterly-Revenue-in-Company-History?id=357680
NASDAQ
CANB
The Badguy
Spot On, CANB is Expanding and Growing Rapidly.
Here it is again for the individual who is in denial.
:
Key Financial Highlights for Q1 2022
Revenue increased 606% to $1.9 million
Gross profit increased 291% to $0.7 million
Adjusted EBITDA loss decreased 30% to $0.9 million
Total assets increased to $17.0 million
Total stockholders’ equity increased to $6.2 million
Key Business Highlights for Q1 2022
Solidified and integrated vertical processing capabilities from recent acquisitions
Advanced build-out of first CBD lounge in Miami, Florida
Continuing path for potential NASDAQ up-listing
Hahahahahha CANB expanding salaries and underwater so bad. LOL expanding now that was a good one.
Peace out
LOL! That means CANB is EXPANDING BIG TIME! TSL*'s current liabilities for the quarter ending March 31, 2022 were $21.455B, a 44.22% increase year-over-year. TSL*'s total current liabilities for 2021 were $19.705B, a 38.3% increase from 2020. TSL*'s total current liabilities for 2020 were $14.248B, a 33.57% increase from 2019. Worth over $700 a share
CANB = NASDAQ
The Badguy
Your kidding right? With the debt CANB has it looks like a Bernie Madoff special. Matter of time till this house of cards collapses.
Peace out
No Wonder All The Continued Accumulation. CANB Just Making All the right Future Moves.
:
Key Financial Highlights for Q1 2022
Revenue increased 606% to $1.9 million
Gross profit increased 291% to $0.7 million
Adjusted EBITDA loss decreased 30% to $0.9 million
Total assets increased to $17.0 million
Total stockholders’ equity increased to $6.2 million
Key Business Highlights for Q1 2022
Solidified and integrated vertical processing capabilities from recent acquisitions
Advanced build-out of first CBD lounge in Miami, Florida
Continuing path for potential NASDAQ up-listing
Management Commentary
CANB had an accumulated deficit of $77,766,659. LOL
Correct, Upward Trajectory Continues. CANB closing in on its 3 month high as Accumulation Continues.
Keep an eye on "penny" we might be close to the NASDAQ
Yip, exactly why CANB always has loading eod. Very easy to see
NASDAQ
CANB
The Badguy
Correct Nasdaq Coming, no wonder Investors continue to Load and Hold these golden shares.
CANB Continues to make All the Right Moves, AND…add to the list Record Quarterly Earnings, Impressive.
*Debt Elimination Continues
*Expansion Continues
*New Products
*New Partners
*Continued Growth
*Nasdaq Coming
CANB had an accumulated deficit of $77,766,659. LOL Did you see this?
You'd have a better chance of striking oil in your yard then this trainwreck.
Peace out
NASDAQ COMING! CANB WILL BE AN INDUSTRY LEADER IN THE HMEP/CBD MARKET
Vision
NASDAQ
CANB
The Badguy
CANB incurred a net loss of $10,266,007 during the year ended December 31, 2021 and as of that date, had an accumulated deficit of $77,766,659.
Good grief they sure know how to run a OTC cesspool play, that is for sure. What a trainwreck.
Peace out
Spot On, CANB Accumulation Continues. Easy to see why, Smart Investors know Nasdaq is coming.
CANB Continues to make All the Right Moves, AND…add to the list Record Quarterly Earnings, Impressive.
*Debt Elimination Continues
*Expansion Continues
*New Products
*New Partners
*Continued Growth
*Nasdaq Coming
Nice accumulation end of day.....again!
NASDAQ
CANB
The Badguy
What’s the opposite of above me???
LOOK OUT BELOWWWW. CANB IS TOAST!
Real value of this pig is trips after all the RS's.
Peace out
"Toast?" LMAO! I see nothing but buying end of day. It's quite apparent too
NASDAQ
CANB
The Badguy
After past RS's I think toast is burnt. CANB true value is now trips and they cannot possibly get past that MASSIVE debt.
Peace out
Can't wait until CANB releases its S-1 for uplist to NASDAQ
It will be epic. I foresee forwards splits on NASDAQ
Vision
CANB
The Badguy
.
Did you see the debt of CANB? GOOD GRIEF!
“ The Company incurred a net loss of $10,266,007 during the year ended December 31, 2021 and as of that date, had an accumulated deficit of $77,766,659. Due to recurring losses from operations and the accumulated deficit the Company has stated that substantial doubt exists about the Company’s ability to continue as a going concern.”
Could not imagine waking or wanting to get up in the am with numbers like that.
Peace out
CANB = NASDAQ NASDAQ NASDAQ!
S1 to uplist will come
Vision
CANB
The Badguy
CANB real value after two RS's is trips. No way they get NASDAQ as they fleeced share holders twice.
Happy 4th of July
Peace out
CANB getting ready for the S-1 to NASDAQ
Watch!
CANB
The Badguy
Great to see you at CANB board and the DD is always welcomed.
Have a great 4th of July all.
Peace out
Maybe another RS to really get to NASDAQ. LOLOLOL
This is never ever going to NASDAQ. Mark it
Correct, it’s only a matter of time before CANB goes to the Nasdaq. Nice almost 14% Gain today :)
CANB Continues to make All the Right Moves, AND…add to the list Record Quarterly Earnings, Impressive.
*Debt Elimination Continues
*Expansion Continues
*New Products
*New Partners
*Continued Growth
*Nasdaq Coming
I agree! NASDAQ right around the corner!
VISION!
CANB
The Badguy
“ As shown in the financial statements, the Company incurred a net loss of $10,266,007 during the year ended December 31, 2021 and as of that date, had an accumulated deficit of $77,766,659. Due to recurring losses from operations and the accumulated deficit the Company has stated that substantial doubt exists about the Company’s ability to continue as a going concern.”
Other CBD coffee company just closed the doors. Wanderport is now in NFTs as the coffee CBD thing was a massive bust.
Waste of time and money from the looks of it. CANB will need a 3rd RS near future.
Peace out
$CANB $GHAV Grand Havana, Inc. Launches Grand Havana CBD Infused Coffee with Can B Corp, Inc. Adding Dr. Peter Michael as its Brand Ambassador to represent Grand Havana CBD infused Coffee
https://www.globenewswire.com/news-release/2022/06/21/2466280/0/en/Grand-Havana-Inc-Launches-Grand-Havana-CBD-Infused-Coffee-with-Can-B-Corp-Inc-Adding-Dr-Peter-Michael-as-its-Brand-Ambassador-to-represent-Grand-Havana-CBD-infused-Coffee.html
Miami, FL, June 21, 2022 (GLOBE NEWSWIRE) -- Grand Havana, Inc. (OTC Pink: GHAV) (“GHAV or the “Company”), is pleased to announce the signing of an agreement (“Agreement”) with Can B Corp, Inc. (OTCQB: CANB) (“CANB”), a health and wellness company specializing in developing, producing and selling hemp-derived cannabinoid products.
Under the terms of the Agreement, Havana will assist Can B in the research and development of a proprietary CBD additive (“Additive”) that Havana will add to their production process to allow the CBD to be infused in the coffee once brewed. The actual Additive manufacturing will be done in Can B’s Miami, Florida R&D lab and processing center or other production facilities as needed.
To expedite time to market, Havana intends to leverage its scalable network of manufacturing and distribution centers throughout Florida in addition to Can B commitment to add the CBD Coffee to its product offerings. The new CBD infused coffee will be available in Havana’s optimum blend medium dark roast in a 12-ounce double zipped bag with an air valve for freshness.
Furthermore, the company has signed a partnership agreement with Peter Michael MD MBA a certified specialist with the ability to provide medical marijuana card evaluations. Under the agreement, Dr. Peter Michael will be the face of the 12oz Grand Havana CBD Infused coffee.
Grand Havana is now taking pre-orders on our company website www.grandhavanacoffee.com
Tanya Bredemeier Chief Executive Officer of Grand Havana, Inc. commented, “After numerous discussions and much consideration, the Company is happy to have finally found the right commercialization and brand development partner with Can B to bring CBD infused coffee product to fruition”. Ms. Bredemeier further added “We welcome Dr. Peter Michael onboard and look forward to branding our CBD coffee as the best products in the market we are using the Company’s flagship dark roast Cuban style espresso brand, Grand Havana, will also be the first to offer CBD-infused espresso, which will be made available to consumers as soon as possible in our cafes and online”. Havana currently services over 1,000 retailers in the southeast market and is looking to expand.
Marco Alfonsi, Can B’s Chief Executive Officer, stated, “This is a significant expansion milestone for our company as coffee is still America’s favorite beverage and its popularity continues to grow”. Added Mr. Alfonsi, “the CBD opportunity with Havana is evidence of the growing market wide expansion into the CBD beverage opportunity and we are glad to be linked with Grand Havana, Inc”.
Dr. Peter Michael states “As a certified regenerative medicine and anti-aging specialist I have been using CBD to help my patients in a variety of ways. The CBD, produced by CANB Corp., blended with Grand Havana espresso delivers an effective combination of flavor, focus and energy.” The product is designed to enhance alertness, relieve stress and provide energy through the synergistic effects of caffeine and CBD in dopamine and serotonin.
Spot On, it’s only a matter of time before CANB goes to the Nasdaq.
CANB Continues to make All the Right Moves, AND…add to the list Record Quarterly Earnings, Impressive.
*Debt Elimination Continues
*Expansion Continues
*New Products
*New Partners
*Continued Growth
*Nasdaq Coming
Zero chance CANB goes to NASDAQ! Mark it and I will never post here again if that happens as its a joke of the OTC.
Peace out
CANB and NASDAQ
The 2 go hand-in-hand
CANB
The Badguy
CANB will NEVER EVER be NASDAQ. Too funny and enjoy the kool-aid.
Peace out
Prob see that s1 get refiled. Offering is over 5 dollars
Question...
Why when you looking at the Trades tab does it say Nasdaq for exchange??? We're stuck in OTC shitville right now. Anyone know why the Trade Tab says NASD for out exchange???
CANB is over and done. Had 2 RS's and may need another soon. Too funny as this is what the OTC cesspool looks like and CANB is a poster child.
Real value pre RS is now trips!
Peace out
They are literally stealing money. Literally don’t sink a penny in this garbage.
$CANB Highest Quarterly Revenues Can B Corp. Reports First Quarter Revenue Growth of 606% to $1.9 Million, the Highest Quarterly Revenue in Company History https://t.co/4pbFDuHBVF
Twitter Post
Can B Corp. Reports First Quarter Revenue Growth of 606% to $1.9 Million, the Highest Quarterly Revenue in Company History
https://canbcorp.com/canbcorp-investors.html?qmodStoryID=6278330803449426
Misleading.. Again. CANB Continues to make All the Right Moves, add to the list Record Quarterly Earnings, Impressive.
*Debt Elimination Continues
*Expansion Continues
*New Products
*New Partners
*Continued Growth
*Nasdaq Coming
THE HIGHEST QUARTERLY REVENUE IN COMPANY HISTORY, Very Impressive Indeed:
Can B Corp. Reports First Quarter Revenue Growth of 606% to $1.9 Million, the Highest Quarterly Revenue in Company History
May 18 2022 - 07:26AM
InvestorsHub NewsWire
Alert
Print
Share On Facebook
Strengthened Balance Sheet with Increases to $17.0 Million in Total Assets and $6.2 Million in Stockholders Equity
HICKSVILLE, NY -- May 18, 2022 -- InvestorsHub NewsWire -- Can B Corp. (OTCQB: CANB) (“Can B'' or the “Company”), a health and wellness company specializing in developing, producing, and selling hemp-derived cannabinoid products, today announced the Company's financial results for the first quarter ended March 31, 2022.
Key Financial Highlights for Q1 2022
Revenue increased 606% to $1.9 million
Gross profit increased 291% to $0.7 million
Adjusted EBITDA loss decreased 30% to $0.9 million
Total assets increased to $17.0 million
Total stockholders’ equity increased to $6.2 million
Key Business Highlights for Q1 2022
Solidified and integrated vertical processing capabilities from recent acquisitions
Advanced build-out of first CBD lounge in Miami, Florida
Continuing path for potential NASDAQ up-listing
Management Commentary
Marco Alfonsi, Can B’s Chief Executive Officer, stated, “We are extremely pleased with our tremendous quarterly results, having achieved the highest quarterly revenue in our company history. We generated the $1.9 million in quarterly revenue while reducing our cash burn as demonstrated by the decrease in adjusted EBITDA to $0.9 million. The strategic moves we have made over the past several months have completed our vertical processing capabilities and put us in great position to accelerate our revenue growth and strengthen our balance sheet. This quarter’s results prove our plans are working as our team continues its hard at work integrating and ramping up the various operations to continue this momentum into the future.”
Alfonsi concluded, “Can B is now a full-service hemp-derived cannabinoid company that can facilitate servicing the large box types as well as the boutique vape and smoke store. Our dramatic revenue improvements, coupled with our acquisitions and asset base increases, position us solidly to continue our application process for a NASDA up listing.”
Vertical Processing Capabilities
Secured hemp biomass and winterized crude to create over 13,000 Liters (1 Liter = 1.05 Quarts) of isomers, including Delta-8, with a potential wholesale value exceeding $10 million at today's market price. Can B's late 2021 acquired facilities in Colorado will receive harvested hemp biomass and convert it to winterized crude. These same facilities will then process it to distillate, then to isolate which will be shipped to Company-owned facilities in Florida and Tennessee to produce Delta-8 or other isomers, or to its manufacturing facility in Lacey, Washington for its line of CBD tinctures, salves, gels, and drops. This processing is expected to take 5-6 months to produce 13,000 liters of Delta-8 and other isomers with potential revenue of $10 million.
300,000 Square Foot Facility in McMinnville, Tennessee
Acquisition of Assets from TWS Pharma included leases on a total of 15,000 square foot of facilities located in Mead and Ft. Morgan Colorado.
Acquisition of Assets from Music City Botanicals added additional volume in extraction, isomer lab production, and R&D into the evolving isomer market with such products as Delta-10, CBG, CBN, and CBDA.
Financial Results for the Three Months Ended March 31, 2022:
Revenue: For the three months ended March 31, 2022, revenue was $1.9 million, an increase of $1.6 million, or 606%, compared with $0.3 million for the same period last year. The increase is due to the wind-down of restrictions related to the Covid-19 Pandemic surrounding elective surgeries, enabling an increase in the usage of the Company’s Duramed product lines and ultrasound device associated with patient recovery. Additionally, due to asset acquisitions in 2021, the Company’s Music City Botanical and Botanical Biotech brands related to an increase in sales compared to 2021 of $0.6 million.
Gross Profit: For the three months ended March 31, 2022, gross profit was $0.7 million, an increase of $0.4 million, or 291%, compared with $0.2 million for the same period last year. The resulting gross margin was 36.0%, compared with 75.0% for the same period last year.
Total Operating Expenses: For the three months ended March 31, 2022, total operating expenses were $3.9 million, an increase of $1.8 million, or 91%, compared with $2.0 million for the same period last year, as a direct result of professional fees and other accounting and legal fees related to the Company’s registration statement S-1 filing efforts.
Of note, $2.3 million of the Company's operating expenses for the three months ended March 31, 2022, were non-cash expenses, including depreciation, amortization, and stock-based compensation, compared to $0.5 million for the same period last year.
Operating Loss: For the three months ended March 31, 2022, operating loss was $3.2 million, an increase of $1.4 million, compared with an operating loss of $1.8 million for the same period last year.
Adjusted EBITDA Loss: For the three months ended March 31, 2022, Adjusted EBITDA loss was $0.9 million, a decrease of $0.4 million, or 30%, compared with an Adjusted EBITDA loss of $1.3 million for the same period last year, after deducting non-cash and one-time expenses.
Net Loss: For the three months ended March 31, 2022, net loss was $3.5 million, an increase of $1.3 million, or 60%, compared with $2.2 million for the same period last year. The EPS loss per share for the three months ended March 31, 2022, was ($1.10), compared to ($3.58) for the same period last year.
About Can B Corp.
Can B Corp. (OTCQB: CANB) is a health & wellness company providing the highest quality hemp-derived cannabinoid products, including under its own brands of Canbiola, Seven Chakras, NuWellness, Pure Leaf Oil, and Duramed. Can B utilizes multi-channel distribution to reach consumers, including medical facilities, doctor offices, retailers, online and direct. Can B Corp. operates R&D and production facilities in Lacey, WA, and Florida. To learn more about Can B Corp. and our comprehensive line of high-quality products, please visit: Canbiola.com and www.CanBCorp.com, follow Can B Corp on Instagram and Facebook or visit one of the 1,000+ retail outlets that carry Can B Corp. products.
For more information about Can B Corp., please visit: CanBCorp.com
Twitter @CanBCorp
Instagram @canbcorp
Facebook @ Can B Corp
YouTube
Stick a fork in the CANB stuffed pig. After all the RS's its true value is trips. Share holders were so screwed here and no way they could ever get back to even.
USE EXTREME CAUTION!
CANB may need a 3rd RS in the future as this is done.
Peace out
"Can B Corp. Reports First Quarter Revenue Growth of 606% to $1.9 Million, the Highest Quarterly Revenue in Company History"
https://ih.advfn.com/stock-market/USOTC/can-b-qb-CANB/stock-news/88146793/can-b-corp-reports-first-quarter-revenue-growth-o
Much, MUCH more to come
NASDAQ
CANB
The Badguy
Followers
|
285
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
30498
|
Created
|
06/18/11
|
Type
|
Free
|
Moderators waterchaser |
These brands include Canbiola, developed for the medical community, Seven Chakras, a spa line, NuWellness for independent Pharmacies and Pure Leaf Oil, their flagship consumer brand.
A growing line of other consumer products are also being developed, with exclusive partner agreements, to sell topical topicals, beverages and ingestible products under the LifeGuard® Brand. The company is launching a full line of Sunscreens, Lip Balms, Replenish Supplements and Water in the summer of 2020. In addition, a line of nutritional supplements called Superfoods, is being readied for a launch at the same time.
Their R&D and production facility is in Lacey WA. There they create, tests, and with a proprietary processes, produce the company’s CBD line of products and private label products to the industry’s highest standards.
CanB owns and operates Green Grow Farms, which is licensed to grow and cultivate Hemp in the State of New York.
Through the Duramed Division, the company offers FDA approved medical devices that alleviate joint, bone and muscle pain from injuries and surgery. Sold through doctors and the medical community, they are considered an important part of the solution to solving the opioid crisis.
http://www.canbcorp.com/
https://canbiola.com
https://duramed.us
https://www.otcmarkets.com/stock/CANB/security
Canbiola, Inc. (OTCQB: CANB) Announces the Formation of a New Wholly Owned Subsidiary- DuraMed, Inc
https://duramed.us
https://www.otcmarkets.com/stock/CANB/news/Canbiola-Inc-OTCQB-CANB-Announces-the-Formation-of-a-New-Wholly-Owned-Subsidiary--DuraMed-Inc?id=216443
SUSTAINED ACOUSTIC MEDICINE (SAMS)
Duramed provides wearable bioelectronic devices for the delivery of sustained acoustic medicine (SAMs). The proprietary miniaturized ultrasound platform is designed for the treatment of acute and chronic musculoskeletal conditions, and clinically proven to enhance tissue recovery, accelerate the natural healing processes, and relieve pain.
The SAM® family of products are the only FDA-cleared wearable devices for multi-hour continuous low intensity ultrasound therapy. SAM has a CE Mark, Canada Licensed, and is a Class II medical device in Malaysia and Singapore.
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |